Supreme court to review immunity of Sacklers from prosecution under a 2019 bankruptcy settlement with the OxyContin maker
The US supreme court will hear oral arguments on Monday on whether members of the wealthy Sackler family can receive immunity from civil prosecution under a 2019 bankruptcy deal agreed on with Purdue Pharma, the former manufacturer of prescription painkiller OxyContin.
Under a court reorganization plan, Sackler family members who controlled the Oxycontin maker were granted immunity and did not have to declare personal bankruptcy in exchange for a $6bn settlement, paid out over 10 years, to a fund created to offset costs created by the opioid dependency crisis that has cost hundreds of thousands of lives.
About Author
More Stories
Qantas posts $1.39bn profit as holidaymakers flock to Jetstar
#AltGov: the secret network of federal workers resisting Doge from the inside
Chinese fishing fleets using North Korean forced labour in potential breach of sanctions, report claims